HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ries, S. Articles by Schmitz, G. Search for Related Content PubMed PubMed Citation Articles by Ries, S. Articles by Schmitz, G. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1761-1765, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred

S Ries, C Aslanidis, P Fehringer, JC Carel, D Gendrel and G Schmitz
Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany.

Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL). The strikingly more severe course of WD is caused by genetic defects of LAL that leave no residual enzymatic activity. Mutations at the exon 8/intron 8 transition of the LAL gene have been identified in several CESD and WD patients and are responsible for the manifestation of the disease. We have determined the genetic defect in a 3-month-old boy of African origin affected by WD. No enzymatic activity of the lysosomal acid lipase was detectable in white blood cells and cultured fibroblasts. Analysis of his LAL cDNA and genomic DNA revealed that he was homozygous for a mutation at position -3 of the exon 8 splice donor site. A C-->T transition leads to a nonsense codon and to a premature termination of the LAL protein at amino acid 277. Due to this mutation, a shorter LAL mRNA species was also generated that lacked exon 8 and was deficient of the nonsense codon. As a consequence, the protein synthesis proceeded to the natural termination codon, but the enzyme generated had an internal deletion of 24 amino acids (254-277) and was also inactive. These findings, together with our previous observations when analyzing the mutations in WD and CESD patients lead to the conclusion that the more severe WD is due to mutations that absolutely abolish lysosomal acid lipase (LAL) enzyme activity and the cholesteryl ester storage disease phenotype is due to mutations that allow some residual LAL activity to be manifested.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Sahashi, A. Masuda, T. Matsuura, J. Shinmi, Z. Zhang, Y. Takeshima, M. Matsuo, G. Sobue, and K. Ohno In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites Nucleic Acids Res., September 25, 2007; 35(18): 5995 - 6003. [Abstract] [Full Text] [PDF]

				O. Zschenker, N. Jung, J. Rethmeier, S. Trautwein, S. Hertel, M. Zeigler, and D. Ameis Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease J. Lipid Res., July 1, 2001; 42(7): 1033 - 1040. [Abstract] [Full Text] [PDF]

				P. Lohse, S. Maas, P. Lohse, M. Elleder, J. M. Kirk, G. T. N. Besley, and D. Seidel Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease J. Lipid Res., January 1, 2000; 41(1): 23 - 31. [Abstract] [Full Text]

				P. Lohse, S. Maas, P. Lohse, A. C. Sewell, O. P. van Diggelen, and D. Seidel Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease J. Lipid Res., February 1, 1999; 40(2): 221 - 228. [Abstract] [Full Text]

				S. Ries, C. Büchler, T. Langmann, P. Fehringer, C. Aslanidis, and G. Schmitz Transcriptional regulation of lysosomal acid lipase in differentiating monocytes is mediated by transcription factors Sp1 and AP-2 J. Lipid Res., November 1, 1998; 39(11): 2125 - 2134. [Abstract] [Full Text]

				F. Pagani, R. Pariyarath, R. Garcia, C. Stuani, A. B. Burlina, G. Ruotolo, M. Rabusin, and F. E. Baralle New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease J. Lipid Res., July 1, 1998; 39(7): 1382 - 1388. [Abstract] [Full Text]